Development and validation of the health assessment questionnaire II: a revised version of the health assessment questionnaire

scientific article published on 01 October 2004

Development and validation of the health assessment questionnaire II: a revised version of the health assessment questionnaire is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/ART.20549
P698PubMed publication ID15476213

P50authorKaleb MichaudQ60309895
P2093author name stringTheodore Pincus
Frederick Wolfe
P433issue10
P304page(s)3296-3305
P577publication date2004-10-01
P1433published inArthritis and RheumatismQ23929027
P1476titleDevelopment and validation of the health assessment questionnaire II: a revised version of the health assessment questionnaire
P478volume50

Reverse relations

cites work (P2860)
Q37456247A Randomized, Double-Blind, Active- and Placebo-Controlled Efficacy and Safety Study of Arhalofenate for Reducing Flare in Patients With Gout
Q36087437A comparison of the measurement properties of the Juvenile Arthritis Functional Assessment Scale with the childhood health assessment questionnaire in daily practice
Q35893925A computer-adaptive disability instrument for lower extremity osteoarthritis research demonstrated promising breadth, precision, and reliability
Q35986276A psychometric assessment of the St. George's respiratory questionnaire in patients with COPD using Rasch model analysis
Q53604189Are chemotherapy patients' HRQoL importance weights consistent with linear scoring rules? A stated-choice approach.
Q84430492Assessment and treatment of psoriatic spondylitis
Q40275209Assessment of muscle mass relative to fat mass and associations with physical functioning in rheumatoid arthritis
Q33596873Associations of smoking and alcohol consumption with disease activity and functional status in rheumatoid arthritis
Q33456382Calibration of the PROMIS physical function item bank in Dutch patients with rheumatoid arthritis
Q63683454Cardiovascular Disease Risk in Older Adults and Elderly Patients with Rheumatoid Arthritis: What Role Can Disease-Modifying Antirheumatic Drugs Play in Cardiovascular Risk Reduction?
Q34192955Challenges comparing functional limitations in rheumatoid arthritis and ankylosing spondylitis
Q33783212Comparison of the Effects of a Pharmaceutical Industry Decision Guide and Decision Aids on Patient Choice to Intensify Therapy in Rheumatoid Arthritis
Q36001279Deficits in muscle mass, muscle density, and modified associations with fat in rheumatoid arthritis
Q47648732Detecting functional change in response to exercise in knee osteoarthritis: a comparison of two computerized adaptive tests
Q37329497Development and evaluation of a crosswalk between the SF-36 physical functioning scale and Health Assessment Questionnaire disability index in rheumatoid arthritis.
Q36832455Development of an Expanded Measure of Physical Functioning for Older Persons in Epidemiologic Research.
Q90413147Digital Tracking of Rheumatoid Arthritis Longitudinally (DIGITAL) Using Biosensor and Patient-Reported Outcome Data: Protocol for a Real-World Study
Q35233200Do patient-reported outcome measures cover personal factors important to people with rheumatoid arthritis? A mixed methods design using the International Classification of Functioning, Disability and Health as frame of reference
Q33454543Dutch translation and cross-cultural adaptation of the PROMIS® physical function item bank and cognitive pre-test in Dutch arthritis patients
Q34279148Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer
Q64091747Effects of a footwear intervention on foot pain and disability in people with gout: a randomised controlled trial
Q36892258Employee health and presenteeism: a systematic review
Q47104420Establishing the Validity and Reliability Evidence of Preceptor Assessment of Student Tool
Q92681376Estimates of Responsiveness, Minimally Important Differences, and Patient Acceptable Symptom State in Five Patient-Reported Outcomes Measurement Information System Short Forms in Systemic Lupus Erythematosus
Q35638560Evaluation of a modified ACR20 scoring system in patients with rheumatoid arthritis receiving treatment with etanercept
Q37377948Evaluation of a patient decision aid for initiating disease modifying anti-rheumatic drugs.
Q48160536Experiences of gout-related disability from the patients' perspective: a mixed methods study
Q35892991Foot and ankle characteristics associated with falls in adults with established rheumatoid arthritis: a cross-sectional study
Q34929669Influence of patient characteristics on perceived risks and willingness to take a proposed anti-rheumatic drug
Q36732747Insulin-like Growth Factor 1 and Adiponectin and Associations with Muscle Deficits, Disease Characteristics, and Treatments in Rheumatoid Arthritis
Q87883462Intramuscular Fat Accumulation and Associations With Body Composition, Strength, and Physical Functioning in Patients With Rheumatoid Arthritis
Q37848117Introduction to economic modeling for clinical rheumatologists: application to biologic agents in rheumatoid arthritis
Q56338557Long-term clinical outcomes of Zika-associated Guillain-Barré syndrome
Q90146973Longitudinal Occurrence and Predictors of Patient-Provider Discordance Between Global Assessments of Disease Activity in Rheumatoid Arthritis: A Case-Control Study
Q34916347MRI bone oedema scores are higher in the arthritis mutilans form of psoriatic arthritis and correlate with high radiographic scores for joint damage
Q37953471Measurement properties of physical function scales validated for use in patients with rheumatoid arthritis: a systematic review of the literature
Q33234551Measuring disease activity for rheumatoid arthritis
Q33459408Measuring everyday functional competence using the Rasch assessment of everyday activity limitations (REAL) item bank.
Q39550704Metabolic syndrome and insulin resistance comorbidity in systemic lupus erythematosus. Effect on carotid intima-media thickness
Q34462876Modern psychometrics applied in rheumatology--a systematic review
Q46442996Muscle Deficits in Rheumatoid Arthritis Contribute to Inferior Cortical Bone Structure and Trabecular Bone Mineral Density
Q38195568Patient involvement in outcome measures for psoriatic arthritis
Q41670046Patient-provider discordance between global assessments of disease activity in rheumatoid arthritis: a comprehensive clinical evaluation
Q55655944Prediction of primary non-response to methotrexate therapy using demographic, clinical and psychosocial variables: results from the UK Rheumatoid Arthritis Medication Study (RAMS).
Q52572093Predictors of activity limitation in people with gout: a prospective study
Q45629572Psychometric evaluation of the WHOQOL-BREF in community-dwelling older people in Taiwan using Rasch analysis
Q36204125QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries
Q36780940Quantitative measures to assess patients with rheumatic diseases: 2006 update
Q55241374Rasch analysis suggests that health assessment questionnaire II is a generic measure of physical functioning for rheumatic diseases: a cross-sectional study.
Q35073601Reduced creatinine clearance is associated with early development of subcutaneous tophi in people with gout
Q36200687Reliability of the TekScan MatScan® system for the measurement of postural stability in older people with rheumatoid arthritis
Q35449556Remission of rheumatoid arthritis in clinical practice: application of the American College of Rheumatology/European League Against Rheumatism 2011 remission criteria
Q33637603Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice
Q48513739Stated preferences of patients with cancer for health-related quality-of-life (HRQOL) domains during treatment
Q33456417The PROMIS Physical Function item bank was calibrated to a standardized metric and shown to improve measurement efficiency
Q33725571The Patient Global Assessment of Disease Activity in Rheumatoid Arthritis: Identification of Underlying Latent Factors
Q37544776The cost and impact of health conditions on presenteeism to employers: a review of the literature
Q45033567The experience and impact of gout in Māori and Pacific people: a prospective observational study
Q34505894Topical Ginger Treatment With a Compress or Patch for Osteoarthritis Symptoms
Q57469543Towards standardized patient reported physical function outcome reporting: linking ten commonly used questionnaires to a common metric
Q34618811Treatment and nontreatment predictors of health assessment questionnaire disability progression in rheumatoid arthritis: a longitudinal study of 18,485 patients
Q33871735Use of accommodations for valued life activities: prevalence and effects on disability scores
Q36302285Usefulness of patients-reported outcomes in rheumatoid arthritis focus group
Q33455269Validation of a mobility item bank for older patients in primary care
Q35953509Validation of the ABILHAND questionnaire as a measure of manual ability in patients with rheumatoid arthritis
Q58220872Validation of the Musculoskeletal Health Questionnaire in inflammatory arthritis: a psychometric evaluation
Q37207061Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study

Search more.